UNH Sees $2.6 Million Bearish Put Bet as Stock Trades Near Midpoint of 52-Week Range

By TrendSpider Editor

UnitedHealth Group attracted notable bearish options activity on Friday, August 28, with a single $2,623,250 put contract flagging as unusual while shares slipped 0.46% to $393.17. The contract targets the $350 strike, sitting well out of the money relative to the current price, with expiration exte

UNH Sees $2.6 Million Bearish Put Bet as Stock Trades Near Midpoint of 52-Week Range

UnitedHealth Group attracted notable bearish options activity on Friday, August 28, with a single $2,623,250 put contract flagging as unusual while shares slipped 0.46% to $393.17. The contract targets the $350 strike, sitting well out of the money relative to the current price, with expiration extending out to March 19, 2027. With UNH trading in the middle of its 52-week range of $255.97 to $461.00, the bet suggests at least one large player is positioning for meaningful downside over the next several months.

Key Drivers of the UNH Stock Move

• Main Catalyst: A single put contract at the $350 strike expiring March 19, 2027 printed with 1,499 contracts and $2,623,250 in total premium, with open interest utilization running at 151% of existing open interest, signaling this is fresh, aggressive positioning rather than a hedge against an existing long.
• Bull Case: The $350 strike is roughly 11% below the current price of $393.17, meaning UNH has a meaningful cushion before this bet pays off. The stock remains more than 53% above its 52-week low of $255.97, reflecting a durable recovery off the lows.
• Bear Case: The 151% open interest ratio is a red flag, indicating the volume of this single trade exceeded existing open interest at that strike, which often signals a conviction directional bet. The March 2027 expiry gives the trade a long runway, implying the buyer expects sustained pressure rather than a brief pullback.

The forward setup for UNH carries real uncertainty. The stock has recovered significantly from its 52-week low but remains well off its high of $461.00, and large out-of-the-money put activity of this size often reflects macro or sector-level concern rather than purely company-specific risk. Healthcare insurers broadly have faced margin pressure from elevated medical cost ratios, regulatory scrutiny around Medicare Advantage reimbursement, and ongoing political attention to the insurance industry's pricing and claims practices. A put expiring in March 2027 also brackets a period that will include the next round of Medicare Advantage rate announcements and likely continued policy debate heading into the legislative calendar, both of which could act as catalysts in either direction for UNH.

UNH Unusual Options Activity

One unusual contract was flagged in Friday's session:

• Type: Put | Strike: $350 | Expiry: March 19, 2027 | Volume: 1,499 contracts | Open Interest Utilization: 151% | Total Premium: $2,623,250 | Moneyness: Out of the money

The 151% open interest ratio is the most important signal here. When a single trade consumes more than 100% of existing open interest at a given strike, it typically indicates a new directional position is being established rather than a roll or close of an existing trade. With no call-side unusual activity to offset it, the flow is cleanly one-directional on the bearish side.

UNH Seasonality

Late August and early September have historically been a mixed period for managed care stocks, as investors begin looking ahead to open enrollment season and any Medicare Advantage plan design announcements that could influence 2027 revenue projections. A March 2027 expiry aligns this trade with the timeframe in which those dynamics typically play out in the stock price.

UNH Relative Performance

UNH edged down 0.46% on Friday to $393.17, a modest underperformance on a session-by-session basis. The stock sits roughly 14.7% below its 52-week high of $461.00 but remains 53.6% above its 52-week low of $255.97, indicating the longer-term recovery trend from last year's lows remains structurally intact even as near-term momentum has stalled in the mid-$390s range.